# Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation

> **NCT02097017** · PHASE4 · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 134 (actual)

## Conditions studied

- Pain Alleviation
- Dilatation and Evacuation
- Laminaria Placement

## Interventions

- **DRUG:** Lidocaine
- **OTHER:** placebo comparator

## Key facts

- **NCT ID:** NCT02097017
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-01
- **Primary completion:** 2018-08-01
- **Final completion:** 2018-08-01
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097017, "Prophylactic Lidocaine Spray for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Second Trimester Dilatation and Evacuation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02097017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*